Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2003
11/20/2003US20030213920 Methods for sterilizing preparations containing albumin
11/20/2003CA2492044A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003CA2485655A1 Recombinant fowlpox virus
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/20/2003CA2485439A1 Anth1 chimeric antagonist
11/20/2003CA2485373A1 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003CA2485252A1 Methods of using thiazolidine derivatives to treat cancer or inflammation
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484835A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003CA2484770A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003CA2484398A1 Method for reducing pain using oncolytic viruses
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2451081A1 Adenosine a<sb>3</sb> receptor modulators
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362853A1 Styrene derivatives and process for production thereof
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362592A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kB
11/19/2003EP1362588A1 Medicinal compositions comprising diclofenac and ornoprostil
11/19/2003EP1362585A2 Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
11/19/2003EP1362108A2 Novel human protease and polynucleotides encoding the same
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1361864A2 Mucoadhesive pharmaceutical formulations
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1178046B1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
11/19/2003EP1086124B1 Novel cyclosporins
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/19/2003EP0984970B1 Spiro-quinuclidine derivatives, their preparation and use
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0831811B1 Carbazoles for treating microbial infections
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457261A Method and compositions for prevention or treatment of cancer
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456657A Healthy medicinal spirit
11/19/2003CN1456334A Preparation of Qingkailing injection
11/19/2003CN1456319A Jingukang capsules for hyperosteogeny
11/19/2003CN1456315A Blood-activating bone-strengthening cream
11/19/2003CN1456282A Preparation of Fengshiling tablets against rheumatism
11/19/2003CN1456278A Broad-spectrum anti-inflammatory antiviral Chinese medicine preparation and preparing method thereof
11/19/2003CN1456273A Blood-activating ointment
11/19/2003CN1456272A Gouty ointment
11/19/2003CN1456264A Preparation of composite south isatis root capsules
11/19/2003CN1456260A Rheumatic strychnos nux-vomica preparing method
11/19/2003CN1456256A Compound pseudo-ginseng preparing method
11/19/2003CN1456252A Rheumatic capsule preparing method
11/19/2003CN1456246A Preparation of tablets against dysmenorrhea
11/19/2003CN1456244A Preparation of capsules against cervitis
11/19/2003CN1456243A Preparation of double coptis root dispersed tablets
11/19/2003CN1456231A Preparation of cold and numbness eliminating pills
11/19/2003CN1456223A Preparation of gastrodia tuber Toufengling pills
11/19/2003CN1456211A Medicine for curing pectoralgia
11/19/2003CN1456208A Blood-activating cream
11/19/2003CN1456199A Chinese medicinal preparation for expelling wind and removing numbness and preparing method thereof
11/19/2003CN1456196A Yunnan Hongyao extractives and application thereof
11/19/2003CN1456184A Appendicitis instant powdery preparation
11/19/2003CN1456153A Preparing method for Xiatianwu alkaloids
11/19/2003CN1456152A Lyophilized preparation of civeleth sodium
11/19/2003CN1127983C Inmunization adjusting anti-inflamation agent
11/19/2003CN1127977C Inflammation-relieving antipyretic syrup
11/19/2003CN1127975C Medicine for treating toothache
11/19/2003CN1127950C Antirheumatic agents
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649658 (−)-Verbenone derivatives
11/18/2003US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649619 Compounds
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649613 Diacylhydrazine derivatives
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649185 For the treatment of cancer; particularly, the formulation can be used to treat haematological malignancies
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003US6649168 Pharmaceutical compositions comprising TGF-beta
11/18/2003US6649164 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/18/2003US6649147 Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/18/2003CA2136071C 2-arylpropionic acid compositions and process for preparing the same
11/18/2003CA2127472C New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
1 ... 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 ... 1272